4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-018516
President and CEO sold 56,303 shares at $15.91 ($896,045)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2022-03-11 | Sale | −56,303 | $15.91 | $896,045 | 1,315,763 | D |
| Open-market sales · 56,303 sh · avg $15.91 · $896,045 | |||||||
Loading xslF345X03/doc4.xml…